BSE filing, NSE: CONCORD. Summary written from the filing by ALFA Finder's alert engine.
Concord Drugs Ltd: key numbers
- Share price
- ₹64.01
- Market cap
- ₹84.33 Cr
- Revenue (annual)
- ₹78.74 Cr
- Net profit (annual)
- ₹1.06 Cr
- P/E (TTM)
- 41.1×Sector 46.1×
- Promoter holding
- 45.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Concord Drugs Ltd
All →Concord Drugs Other Announcement
Concord Drugs Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Concord Drugs Annual General Meeting
Concord Drugs Limited held its 31st Annual General Meeting on September 30, 2026. The meeting covered adoption of financial statements, director appointments, and auditor re-appointment.
Concord Drugs Other Announcement
Concord Drugs Limited is notifying shareholders about the annual report web-link as per Regulation 36(1)(b). Shareholders are urged to update their email addresses.
Concord Drugs Annual General Meeting
Concord Drugs approved the notice for its 31st AGM on September 30, 2026. The board also finalized director re-appointments and set book closure dates.
Concord Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 1000.0% YoY
Concord Drugs Ltd reported revenue from operations of ₹20.9 Cr (+53.7% YoY) and net profit of ₹1.1 Cr (+1000.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +1000.0% YoY
Concord Drugs Board Meeting Date
Concord Drugs Limited scheduled a board meeting on August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other annual report announcements
All →LWS Knitwear Annual Report
LWS Knitwear files its FY 2025-26 Annual Report, including the 37th AGM notice set for 20 November 2026. No single material transaction is announced.
Punjab Communications Annual Report
Punjab Communications filed its 45th Annual Report for FY 2025-26 with BSE under SEBI LODR Reg 34(1). The report includes audited financials, board report, and 45th AGM notice.
Aban Offshore Annual Report
Aban Offshore filed its Annual Report for FY 2025-26, including the 40th AGM notice for 16 November 2026. The company remains under CIRP with powers suspended.
Vipul Annual Report
Vipul Limited submitted its 2025-26 Annual Report and the notice for its 35th Annual General Meeting, scheduled for November 12, 2026.
Supreme Infrastructure India Annual Report
Supreme Infrastructure India Limited filed its Annual Report for FY 2025-26 with the BSE. The report covers corporate overview, statutory reports, and financial statements.
Krishna Filament Industries Annual Report
Krishna Filament Industries has submitted its 38th Annual Report for the financial year 2025-26 along with the Notice of the Annual General Meeting.